Insulet Corp. (NASDAQ:PODD) has been given a consensus rating of “Buy” by the sixteen brokerages that are covering the stock. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $41.58.

Several research analysts have recently issued reports on the company. B. Riley reissued a “neutral” rating and issued a $40.00 price target on shares of Insulet Corp. in a research note on Friday, November 4th. Canaccord Genuity set a $39.00 price target on Insulet Corp. and gave the stock a “hold” rating in a research note on Sunday, November 6th. JPMorgan Chase & Co. reissued a “hold” rating and issued a $38.00 price target on shares of Insulet Corp. in a research note on Thursday. Wedbush reissued an “outperform” rating and issued a $48.00 price target on shares of Insulet Corp. in a research note on Thursday. Finally, Zacks Investment Research upgraded Insulet Corp. from a “hold” rating to a “buy” rating and set a $49.00 price objective for the company in a report on Tuesday, August 9th.

A number of large investors have recently made changes to their positions in the company. Walleye Trading LLC raised its position in shares of Insulet Corp. by 226.3% in the second quarter. Walleye Trading LLC now owns 3,410 shares of the company’s stock valued at $103,000 after buying an additional 6,110 shares during the last quarter. BOKF NA purchased a new position in shares of Insulet Corp. during the second quarter valued at $111,000. BNP Paribas Arbitrage SA raised its position in shares of Insulet Corp. by 113.5% in the second quarter. BNP Paribas Arbitrage SA now owns 3,691 shares of the company’s stock valued at $112,000 after buying an additional 1,962 shares during the last quarter. Bamco Inc. NY purchased a new position in shares of Insulet Corp. during the third quarter valued at $206,000. Finally, Strs Ohio raised its position in shares of Insulet Corp. by 2,750.0% in the third quarter. Strs Ohio now owns 5,700 shares of the company’s stock valued at $233,000 after buying an additional 5,500 shares during the last quarter.

Shares of Insulet Corp. (NASDAQ:PODD) opened at 37.25 on Tuesday. Insulet Corp. has a 52-week low of $23.94 and a 52-week high of $45.60. The stock’s market cap is $2.14 billion. The company’s 50-day moving average price is $37.82 and its 200-day moving average price is $36.10.

Insulet Corp. (NASDAQ:PODD) last released its quarterly earnings results on Thursday, November 3rd. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.09) by $0.04. Insulet Corp. had a negative return on equity of 87.46% and a negative net margin of 12.95%. The company earned $94.90 million during the quarter, compared to analysts’ expectations of $89.75 million. During the same quarter in the prior year, the business posted ($0.33) earnings per share. The company’s revenue for the quarter was up 32.5% compared to the same quarter last year. Analysts expect that Insulet Corp. will post ($0.37) earnings per share for the current year.

About Insulet Corp.

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The OmniPod System consists of the OmniPod, a small, self-adhesive disposable tubeless OmniPod device, which is worn on the body for approximately three days at a time and its wireless handheld Personal Diabetes Manager (PDM).

5 Day Chart for NASDAQ:PODD

Receive News & Stock Ratings for Insulet Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Insulet Corp. and related stocks with our FREE daily email newsletter.